摘要
目的:了解我国医疗机构处方前置审核工作的开展现状,为医疗机构提升前置审核工作质量提供参考。方法:计算机检索PubMed、Cochrane图书馆、Embase(Ovid平台)、中国知网、中国生物医学文献数据库、维普网和万方数据库,检索时限均为建库起至2020年3月,收集我国医疗机构开展处方前置审核工作情况的研究。对符合纳入与排除标准的文献进行资料提取后,进行描述性分析。结果:共纳入38篇文献,涉及医疗机构29所,其中三级甲等医疗机构25所(86.21%)、综合性医疗机构22所(75.86%),工作开展时间为2007-2019年;84.62%的医疗机构采用“系统审核+人工复核”的审核模式,审核处方主要为门(急)诊处方(76.00%),采用该模式的医疗机构主要采取审方药师对系统拦截的问题处方再次复核的模式;8所医疗机构平均问题处方人工复核时间在60 s以内;16所医疗机构报道的审方药师人数为1~8人,1所医疗机构报道的审方药师学历为本科及以上,6所医疗机构报道的审方药师职称为中级及以上(83.33%),11所医疗机构报道以专职审方岗位为主(90.91%)。处方前置审核工作的问题处方干预成功率为93.99%,且可提高医疗机构处方合格率。结论:我国医疗机构处方前置审核工作取得了一定效果,但仍面临信息系统不完善、审方药师能力不足以及医师药师沟通不畅等问题,将是未来开展处方前置审核工作需注意的方面。
OBJECTIVE:To know about the current situation of pre-prescription review in medical institutions in China,and provide reference for quality improvement of pre-prescription review in medical institutions.METHODS:Retrieved from PubMed,the Cochrane library,EMbase(Ovid platform),CNKI,CBM,VIP and Wanfang databases,the studies about pre-prescription review in medical institutions in China were collected during the inception to Mar.2020.After data extraction of the literatures met the inclusion and exclusion criteria,descriptive analysis was used.RESULTS:A total of 38 literatures were included,involving 29 medical institutions,of which 25 were third-grade class-A medical institutions(86.21%),22 comprehensive medical institutions(75.86%);pre-prescription review was carried out from 2007 to 2019.Totally 84.62%of medical institutions adopted the mode of“systematic review+manual review”,and the main audited prescriptions were outpatient(emergency)prescriptions(76.00%).Medical institutions adopting this mode mainly adopted the mode that auditing pharmacists rechecked the problem prescriptions intercepted by the system.The average manual review time of problem prescriptions in 8 medical institutions was within 60 s;the number of auditing pharmacists in 16 reported medical institutions ranged from 1 to 8,and educational degree of auditing pharmacists in 1 reported medical institution were bachelor degree or above.Their professional titles of 6 reported medical institutions were junior or above(83.33%).Eleven medical institutions had full-time auditing posts(90.91%).Success rate of problem prescription intervention was 93.99%;pre-prescription review could increase the qualification rate of prescription.CONCLUSION:The pre-prescription review in medical institutions in China has achieved certain results,but still faces some problems,such as imperfect information system,insufficient ability of auditing pharmacists and poor communication between doctors and pharmacists,which will be the aspects that should be paid attention to in the future.
作者
李汶睿
李頔
赵春景
钱妍
LI Wenrui;LI Di;ZHAO Chunjing;QIAN Yan(Dept.of Pharmacy,the Second Affiliated Hospital of Chongqing Medical University,Chongqing 400010,China)
出处
《中国药房》
CAS
北大核心
2021年第5期524-529,共6页
China Pharmacy
基金
国家自然科学基金资助项目(No.8140293727)
北京康盟慈善基金会临床与基础研究专项(No.HS202003)。
关键词
处方前置审核
医疗机构
现状
Pre-prescription review
Medical institutions
Current Situation